A brief AP activating only a small subset of available presynaptic Cav2 channels leads to neuromuscular weakness after many of these calcium channels are attacked and removed by autoantibodies in the disease LEMS. This evidence concerns the gene CAV2 and Lambert-Eaton myasthenic syndrome.